CA
UTHR icon

Claro Advisors’s United Therapeutics UTHR Stock Holding History

Claro Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$425K Buy
+716
New +$357K 0.05% 278

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Claro Advisors's UTHR Position: Q1 2026 in Review

Claro Advisors opened a new position in United Therapeutics (UTHR) in Q1 2026: 716 shares worth $425K. The stake represents 0.05% of the portfolio and ranks #278 among its holdings.

851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Claro Advisors held 716 shares of United Therapeutics worth $425K as of Q1 2026.
  • United Therapeutics was a new Claro Advisors position in Q1 2026.
  • United Therapeutics made up 0.05% of Claro Advisors's portfolio in Q1 2026, its #278 holding.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Claro Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.